Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 3—March 2026
Research Letter
CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo
Suggested citation for this article
Abstract
We evaluated human Crimean-Congo hemorrhagic fever virus (CCHFV) seroprevalence in hunter-gatherer populations of northeastern Democratic Republic of the Congo. We tested blood from 300 participants for CCHFV antibodies; 4% were CCHFV-positive. CCHFV likely has been circulating undetected in the country, indicating the need for a more robust surveillance system.
Crimean-Congo hemorrhagic fever (CCHF) is a tickborne viral disease that is endemic to sub-Saharan Africa and has a widespread global distribution (1). CCHF virus (CCHFV) belongs to the Orthonairovirus genus, in the Nairoviridae family of the Bunyaviridae order (2). Hyalomma spp. ticks transmit CCHFV through bites, but the virus also can be transmitted to humans via contact with infected blood (1). During outbreaks, case-fatality rates can be as high as 60%, and the incubation period is ≈1–6 days, depending on the transmission route. Infections are characterized by a wide range of symptoms, including but not limited to nonspecific fever, myalgia, headache, diarrhea, nausea, and vomiting (3).
In the Democratic Republic of the Congo (DRC), reported cases have been limited to 2 zoonotic transmissions since 1956 (4,5). Even so, CCHF cases are likely undetected because of limited surveillance in the country. Furthermore, no serologic evaluation in humans has been reported from DRC. To shed light on CCHFV prevalence in the country, we examined blood samples taken from a pygmy hunter-gatherer population in Watsa, in northeastern DRC, a population that has frequent contact with wildlife (6). We recruited 300 participants from 39 different settlements, 150 men and 150 women, whose mean age was 32.2 (SD +14.6) years. Study participants were invited to the study site, where they received informed consent before we administered a questionnaire and collected blood samples. We used a database previously generated as part of a Marburg hemorrhagic fever virus seroprevalence investigation (7) (Appendix) to record interview responses and find evidence of CCHFV circulating within the region.
Using an ELISA assay, we observed a 4% (n = 12) IgG seroprevalence. Most (83.3%, n = 10) of those positive were female; only 2 men were seropositive (odds ratio [OR] = 5.286; p = 0.035). We noted no significant difference in age between the seropositive and seronegative population, and the mean age of seropositive participants did not deviate from mean age of the study population (Table).
Our investigation questionnaire did not ask whether volunteers were involved in farming. Because pygmies’ subsistence activities do not include farming (6), seropositive donors more likely encountered viral vectors in the forest during traditional hunter-gatherer activities. Sociologically, male members of the community are predominantly expected to hunt, bringing home carcasses to be butchered by female members. Among participants, 60% stated they practiced hunting as their primary means of subsistence; the other 40% performed other, unspecified, activities. In contrast to our expectations, nonhunting participants had a higher probability for seropositivity than hunting participants (Table; Appendix Table 1).
Because most seropositive participants were women who did not routinely hunt, and considering the lifestyle of pygmy populations, we speculate that gathering food or butchering carcasses constituted greater CCHFV risk factors (1). However, we cannot exclude the possibility that the nonhunting seropositive female members also undertook farming activities for additional subsistence. Nevertheless, data suggest the possibility that nonfarming activities in the forest could expose humans to CCHFV tick vectors, either through direct interaction in the bushes or via wild animals harboring ticks (8–10).
To help clarify the risk mediated by exposure via wild animals, we asked participants about animal contacts. Rats, bats, monkeys, and other animals in the area are known to carry ticks responsible for CCHFV transmission (8–10). We asked participants whether they touched, ate, or had been bitten by animals; 72% reported encountering rodents (particularly rats), 74.7% encountered bats, and 91% encountered monkeys. Although all 12 seropositive participants confirmed previous contact with monkeys, we did not have sufficient elements to statistically confirm that association (OR = 0; p = 0.610) (Table).
Of the 12 seropositive participants, 6 (50%) reported previously having hemorrhagic fever (HF) symptoms; however, we found no significant correlation between seropositivity and HF symptoms (OR = 0.834; p = 0.776). In addition, we found no correlation between seropositivity and direct or indirect contact with another HF patient or a dead body (Appendix Table 2). That finding supports the possibility that CCHFV seroprevalence and transmission was not through direct or indirect human contact within this community, but rather through zoonotic transmission, further supported by the established correlation between reported subsistence activities and seropositivity (Table).
In conclusion, we documented serologic evidence of CCHF in DRC hunter-gatherer populations, indicating that the disease has been circulating undetected in the country. The lack of previously reported cases is probably the consequence of a nonexistent surveillance system. In addition, the lack of specific diagnostic tools in DRC is a challenge to understanding the epidemiology of the disease. Our findings highlight the need for greater scrutiny into risk factors of CCHFV exposure, particularly among populations exposed to wildlife as part of their lifestyles and in regions with diverse human population groups and cultures.
Dr. Kasumba is an associate professor at the University of Kinshasa and a scientist at the National Institute for Biomedical Research, Kinshasa, DRC. His research interests focus on host-microbe interactions to improve and develop mitigation approaches against infectious diseases.
Acknowledgments
We thank members of the Watsa Rural Health Zone Central Office and the interviewers who made this investigation possible despite the difficult working conditions characterized by security issues. We also thank Antoine Tshomba for facilitating the administrative procedures with local authorities and Janusz Paweska and his team for their crucial and fruitful discussions and support in this analysis.
D.M.K. is supported by the European Union (grant no. DCI-PANAF/2020/420-028) through the African Research Initiative for Scientific Excellence pilot program. ARISE is implemented by the African Academy of Sciences with support from the European Commission and the African Union Commission. D.M.K. also receives additional support from the National Institutes of Health Fogarty Program Global Infectious Diseases through the Emerging and Re-Emerging Pathogens Research Training Program in DRC (EREP-RTP-DRC). The contents of this document are the sole responsibility of the authors and can under no circumstances be regarded as reflecting the position of the European Union, the African Academy of Sciences, the African Union Commission, the National Institutes of Health, the UK Health Security Agency, or the British government.
References
- Temur AI, Kuhn JH, Pecor DB, Apanaskevich DA, Keshtkar-Jahromi M. Epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in Africa—underestimated for decades. Am J Trop Med Hyg. 2021;104:1978–90. DOIPubMedGoogle Scholar
- Kuhn JH, Alkhovsky SV, Avšič-Županc T, Bergeron É, Burt F, Ergünay K, et al. ICTV virus taxonomy profile: Nairoviridae 2024. J Gen Virol. 2024;105:4.PubMedGoogle Scholar
- Frank MG, Weaver G, Raabe V; State of the Clinical Science Working Group of the National Emerging Pathogens Training; Education Center’s Special Pathogens Research Network2; State of the Clinical Science Working Group of the National Emerging Pathogens Training Education Center’s Special Pathogens Research Network. Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention. Emerg Infect Dis. 2024;30:854–63. DOIPubMedGoogle Scholar
- Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW. Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations—clinical notes. East Afr Med J. 1967;44:86–92.PubMedGoogle Scholar
- Woodall JP, Williams MC, Simpson DI. Congo virus: a hitherto undescribed virus occurring in Africa. II. Identification studies. East Afr Med J. 1967;44:93–8.PubMedGoogle Scholar
- Fa JE, Olivero J, Farfán MA, Lewis J, Yasuoka H, Noss A, et al. Differences between Pygmy and non-Pygmy hunting in Congo Basin forests. PLoS One. 2016;11:
e0161703 . DOIPubMedGoogle Scholar - Borchert M, Mulangu S, Swanepoel R, Tshomba A, Afounde A, Kulidri A, et al. Pygmy populations seronegative for Marburg virus. Emerg Infect Dis. 2005;11:174–7. DOIPubMedGoogle Scholar
- Müller MA, Devignot S, Lattwein E, Corman VM, Maganga GD, Gloza-Rausch F, et al. Evidence for widespread infection of African bats with Crimean-Congo hemorrhagic fever-like viruses. Sci Rep. 2016;6:26637. DOIPubMedGoogle Scholar
- Lacroux C, Bonnet S, Pouydebat E, Buysse M, Rahola N, Rakotobe S, et al. Survey of ticks and tick-borne pathogens in wild chimpanzee habitat in Western Uganda. Parasit Vectors. 2023;16:22. DOIPubMedGoogle Scholar
- Omoga DCA, Tchouassi DP, Venter M, Ogola EO, Osalla J, Kopp A, et al. Transmission dynamics of Crimean-Congo haemorrhagic fever virus (CCHFV): evidence of circulation in humans, livestock, and rodents in diverse ecologies in Kenya. Viruses. 2023;15:1891. DOIPubMedGoogle Scholar
Figure
Table
Suggested citation for this article: Kasumba DM, Shamamba SM, Mubiala AY, Bazola BN, Horton AC, Ndawula C, et al. CCHFV seroprevalence among hunter-gatherers, northeastern Democratic Republic of the Congo. Emerg Infect Dis. 2026 Mar [date cited]. https://doi.org/10.3201/eid3203.251171
Original Publication Date: March 10, 2026
Table of Contents – Volume 32, Number 3—March 2026
| EID Search Options |
|---|
|
|
|
|
|
|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Dacquin Muhandwa Kasumba, Institut National de Recherche Biomédicale, 5345 Ave de la Démocratie, Kinshasa-Gombe BP1197, Democratic Republic of the Congo
Top